Orlistat is an anti-obesity drug that acts to decrease the amount of fat that is absorbed by binding to enzymes that digest fat. Which of the following are potential targets of orlistat?

Question

Quizplus · Accepted Answer

Orlistat binds to pancreatic lipase, the enzyme responsible for breaking down dietary fats in the small intestine. This reduces the amount of fat that is absorbed by the body. Salivary amylase and pepsidase are enzymes involved in the digestion of carbohydrates and proteins, respectively, and are not targeted by orlistat. Secretin is a hormone involved in regulating pancreatic enzyme secretion and is also not targeted by orlistat.

Orlistat Is an Anti-Obesity Drug That Acts to Decrease the Amount